BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31723927)

  • 21. Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
    Le C; Chu F; Dunlay R; Villar J; Fedullo P; Wardi G
    Am J Emerg Med; 2018 Aug; 36(8):1380-1385. PubMed ID: 29321120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap?
    Capp R; Chang Y; Brown DF
    J Emerg Med; 2011 Dec; 41(6):573-80. PubMed ID: 21371846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality rate among patients with septic shock after implementation of 6-hour sepsis protocol in the emergency department of Thammasat University Hospital.
    Apibunyopas Y
    J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S182-93. PubMed ID: 25518312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient survival, predictive factors and disease course of severe sepsis in Czech intensive care units: A multicentre, retrospective, observational study.
    Uvizl R; Adamus M; Cerny V; Dusek L; Jarkovsky J; Sramek V; Matejovic M; Stourac P; Kula R; Malaska J; Sevcik P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):287-97. PubMed ID: 26526190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing a collaborative protocol in a sepsis intervention program: lessons learned.
    Casserly B; Baram M; Walsh P; Sucov A; Ward NS; Levy MM
    Lung; 2011 Feb; 189(1):11-9. PubMed ID: 21080182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for mortality despite early protocolized resuscitation for severe sepsis and septic shock in the emergency department.
    Drumheller BC; Agarwal A; Mikkelsen ME; Sante SC; Weber AL; Goyal M; Gaieski DF
    J Crit Care; 2016 Feb; 31(1):13-20. PubMed ID: 26611382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study.
    Im Y; Kang D; Ko RE; Lee YJ; Lim SY; Park S; Na SJ; Chung CR; Park MH; Oh DK; Lim CM; Suh GY;
    Crit Care; 2022 Jan; 26(1):19. PubMed ID: 35027073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors at Index Hospitalization Associated With Longer-term Mortality in Adult Sepsis Survivors.
    Shankar-Hari M; Harrison DA; Ferrando-Vivas P; Rubenfeld GD; Rowan K
    JAMA Netw Open; 2019 May; 2(5):e194900. PubMed ID: 31150081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of physician diagnosis and guideline definitions in identifying sepsis patients in the emergency department.
    Brown T; Ghelani-Allen A; Yeung D; Nguyen HB
    J Crit Care; 2015 Feb; 30(1):71-7. PubMed ID: 25241088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes of Community-Acquired Severe Sepsis after Implementation of a Simple Severe Sepsis Fast Track.
    Ruangchan S; Chusri S; Saengsanga P; Kiamkan N; Phunpairoth P; Chayakul P
    J Med Assoc Thai; 2016 Aug; 99(8):877-85. PubMed ID: 29947488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
    Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
    Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (Sepsis-3).
    Yang WS; Kang HD; Jung SK; Lee YJ; Oh SH; Kim YJ; Sohn CH; Kim WY
    Clin Respir J; 2020 Sep; 14(9):857-863. PubMed ID: 32438528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria.
    Capsoni N; Bellone P; Aliberti S; Sotgiu G; Pavanello D; Visintin B; Callisto E; Saderi L; Soldini D; Lardera L; Monzani V; Brambilla AM
    Multidiscip Respir Med; 2019; 14():23. PubMed ID: 31312449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empiric Antibiotic Therapy for Severe Sepsis and Septic Shock.
    Oshima T; Kodama Y; Takahashi W; Hayashi Y; Iwase S; Kurita T; Saito D; Yamaji Y; Oda S
    Surg Infect (Larchmt); 2016 Apr; 17(2):210-6. PubMed ID: 26630548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sepsis Bundle Adherence Is Associated with Improved Survival in Severe Sepsis or Septic Shock.
    Milano PK; Desai SA; Eiting EA; Hofmann EF; Lam CN; Menchine M
    West J Emerg Med; 2018 Sep; 19(5):774-781. PubMed ID: 30202487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The incidences of organ dysfunction in the early resuscitation of severe sepsis and septic shock patients:a retrospective analysis].
    Wan L; Liao G; Wan X; Huang Y; Huang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):418-22. PubMed ID: 29920036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of a change in septic shock definitions on intensive care epidemiology and outcome: comparison of sepsis-2 and sepsis-3 definitions.
    Driessen RGH; van de Poll MCG; Mol MF; van Mook WNKA; Schnabel RM
    Infect Dis (Lond); 2018 Mar; 50(3):207-213. PubMed ID: 28950786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb SA; Beale RJ; Vincent JL; Moreno R;
    Crit Care Med; 2013 Feb; 41(2):580-637. PubMed ID: 23353941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.